Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-22-021875)

Filing Details

Accession Number:: 0001209191-22-021875
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-03-31 20:51:58
Reporting Period:: 2022-03-31

Accepted Time:: 2022-03-31 20:51:58
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1796280	Oric Pharmaceuticals Inc.	ORIC	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1695028	Dominic Piscitelli	C/O Oric Pharmaceuticals, Inc. 240 E. Grand Ave., 2Nd Floor South San Francisco CA 94080	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-03-31	60,000	$5.36	60,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

Represents the weighted average share price of an aggregate total of 60,000 shares purchased in the price range of $5.25 to $5.46 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.